2023年10月16日~2023年10月22日の間に収集した論文情報を追加しました。
1. Cost of illness due to pertussis in adults >/=50 years of age in the United Kingdom.
英国における百日咳の経済的負担の研究
対象DB:CPRD
2. Electronic health record-wide association study for atrial fibrillation in a British cohort.
心房細動と新たな10の関連疾患について
対象DB:CPRD
3. Antibiotic prescribing in remote versus face-to-face consultations for acute respiratory infections in primary care in England: an observational study using target maximum likelihood estimation.
遠隔診察と対面診察の抗生剤処方の比較
対象DB:CPRD
4. Antidepressants in pregnancy: applying causal epidemiological methods to understand service-use outcomes in women and long-term neurodevelopmental outcomes in exposed children.
抗うつ薬の処方と自閉症との関連性
対象DB:CPRD
5. Optimising prediction of mortality, stroke, and major bleeding for patients with atrial fibrillation: validation of the GARFIELD-AF tool in UK primary care electronic records.
GARFIELD-AF:心房細動患者の死亡リスク、脳卒中や重度出血リスクなどを同時に評価する新しいツール
対象DB:CPRD
6. Prevalence and demographic variation of cardiovascular, renal, metabolic, and mental health conditions in 12 million english primary care records.
心血管、腎臓、代謝および精神健康の疾患の有病率と社会人口統計学的特徴の研究
対象DB:CPRD
7. A Retrospective Database Analysis to Investigate Treatment Patterns and Health Care Resource Utilisation in Patients who CYCLe AntiMuscarinics in ENgland (CYCLAMEN).
過活動膀胱の患者の治療パターンと医療リソースの研究
対象DB:CPRD
8. Inadequate Folic Acid Intake Among Women Taking Antiepileptic Drugs During Pregnancy in Japan: A Cross-Sectional Study.
妊娠中の抗てんかん薬服用と葉酸摂取不足の研究
対象DB:JMDC
9. Epidemiology of sepsis in a Japanese administrative database.
敗血症の患者数増加と治療戦略の研究
対象DB:DPC
10. Association Between Intraoperative Landiolol Use and In-Hospital Mortality After Coronary Artery Bypass Grafting: A Nationwide Observational Study in Japan.
敗血冠動脈バイパス手術のランジオロール使用と、入院中の死亡率の減少について
対象DB:DPC
11. Comparison of prophylactic antibiotics for endonasal transsphenoidal surgery using a national inpatient database in Japan.
内鼻経鼻手術後の髄膜炎予防において、セファゾリン、アンピシリン、第三世代セファロスポリンの効果を比較調査
対象DB:DPC
12. Infections associated with clozapine: a pharmacovigilance study using VigiBase((R)).
クロザピンと感染症のシグナルの研究
対象DB:VigiBase
13. Ondansetron induced blindness: a pharmacovigilance database study.
オンダンセトロンの使用と視力障害の関連性
対象DB:VigiBase
14. Signal Detection and Assessment of Herb-Drug Interactions: Saudi Food and Drug Authority SFDA Experience.
サウジアラビア食品医薬品庁(SFDA)の薬草と薬物の相互作用プロジェクトについて
対象DB:VigiBase
15. Broadening the Capture of Natural Products Mentioned in FAERS Using Fuzzy String-Matching and a Siamese Neural Network.
天然製品(NPs)のファジー文字列マッチングとニューラルネットワークの組み合わせによる解析
対象DB:FAERS
16. Data mining and analysis of the adverse events derived signals of 4 gadolinium-based contrast agents based on the US Food and drug Administration adverse event reporting system.
ガドリニウム系造影剤(GBCAs)に関連する薬剤関連の有害事象の研究
対象DB:FAERS
17. Using natural language processing to characterize and predict homeopathic product-associated adverse events in consumer reviews: comparison to reports to FDA Adverse Event Reporting System (FAERS).
NLPを用いて、Amazon消費者レビューから非承認の自然療法薬に関連する有害事象を特定、FAERSと比較
対象DB:FAERS
18. Rhabdomyolysis associated with newer-generation anti-seizure medications (ASMs): a real-world retrospective and pharmacovigilance study.
新世代のてんかん薬(ASMs)と横紋筋融解症のリスク
対象DB:FAERS
19. Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multi-Center Study.
甲状腺眼症のテプロツマバ治療に伴う有害事象の解析
対象DB:FAERS